Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Medical Liquid Embolic Agents Market Research Report 2024

Global Medical Liquid Embolic Agents Market Research Report 2024

Industry: Pharma & Healthcare

Published: 2024-12-21

Pages: 80 Pages

Report ld: 3407389

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Medical Liquid Embolic Agents was valued at US$ 133 million in the year 2023 and is projected to reach a revised size of US$ 222 million by 2030, growing at a CAGR of 7.6% during the forecast period.

Medical liquid embolic agents are specialized substances used in interventional radiology to block blood flow in targeted blood vessels, typically for treating vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, or tumors. These agents are delivered via a catheter and solidify or precipitate upon contact with blood or tissue, creating a durable embolization effect. Common types include cyanoacrylate glues, ethylene-vinyl alcohol copolymer (EVOH), and onyx-based systems, which vary in composition, viscosity, and application methods. They offer a minimally invasive treatment option, reducing the need for open surgery while providing precise vascular occlusion to manage bleeding or cut off blood supply to abnormal tissues.

Medical Liquid Embolic Agents Market Size

M= millions and B=billions

North American market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Medical Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Medical Liquid Embolic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Liquid Embolic Agents.

The Medical Liquid Embolic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Liquid Embolic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Medical Liquid Embolic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Report Metric
Details
Report Title
Global Medical Liquid Embolic Agents Market Research Report 2024
Forecasted Market Size in 2030
US$ 222 million
CAGR(2024-2030)
7.6%
Market Size Available for Years
2019-2030
Global Medical Liquid Embolic Agents Companies Covered
Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech
Global Medical Liquid Embolic Agents Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Liquid Embolic Agents Market, Segment by Type
EVOH-Based

Diluted Cyanoacrylate

Others
Global Medical Liquid Embolic Agents Market, Segment by Application
Brain Arterio-Venous Malformations (bAVM)

Tumor Embolization

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region,  by Type,  by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Liquid Embolic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Table of Contents

 1 Medical Liquid Embolic Agents Market Overview
    1.1 Product Definition
    1.2 Medical Liquid Embolic Agents by Type
        1.2.1 Global Medical Liquid Embolic Agents Market Value Comparison by Type (2024-2030)
        1.2.2 EVOH-Based
        1.2.3 Diluted Cyanoacrylate
        1.2.4 Others
    1.3 Medical Liquid Embolic Agents by Application
        1.3.1 Global Medical Liquid Embolic Agents Market Value by Application (2024-2030)
        1.3.2 Brain Arterio-Venous Malformations (bAVM)
        1.3.3 Tumor Embolization
        1.3.4 Others
    1.4 Global Medical Liquid Embolic Agents Market Size Estimates and Forecasts
        1.4.1 Global Medical Liquid Embolic Agents Revenue 2019-2030
        1.4.2 Global Medical Liquid Embolic Agents Sales 2019-2030
        1.4.3 Global Medical Liquid Embolic Agents Market Average Price (2019-2030)
    1.5 Assumptions and Limitations

 2 Medical Liquid Embolic Agents Market Competition by Manufacturers
    2.1 Global Medical Liquid Embolic Agents Sales Market Share by Manufacturers (2019-2024)
    2.2 Global Medical Liquid Embolic Agents Revenue Market Share by Manufacturers (2019-2024)
    2.3 Global Medical Liquid Embolic Agents Average Price by Manufacturers (2019-2024)
    2.4 Global Key Players of Medical Liquid Embolic Agents, Industry Ranking, 2022 VS 2023 VS 2024
    2.5 Global Key Manufacturers of Medical Liquid Embolic Agents, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Medical Liquid Embolic Agents, Product Type & Application
    2.7 Global Key Manufacturers of Medical Liquid Embolic Agents, Date of Enter into This Industry
    2.8 Global Medical Liquid Embolic Agents Market Competitive Situation and Trends
        2.8.1 Global Medical Liquid Embolic Agents Market Concentration Rate
        2.8.2 The Global 5 and 10 Largest Medical Liquid Embolic Agents Players Market Share by Revenue
        2.8.3 Global Medical Liquid Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Global Medical Liquid Embolic Agents Market Scenario by Region
    3.1 Global Medical Liquid Embolic Agents Market Size by Region: 2019 Versus 2023 Versus 2030
    3.2 Global Medical Liquid Embolic Agents Sales by Region: 2019-2030
        3.2.1 Global Medical Liquid Embolic Agents Sales by Region: 2019-2024
        3.2.2 Global Medical Liquid Embolic Agents Sales by Region: 2025-2030
    3.3 Global Medical Liquid Embolic Agents Revenue by Region: 2019-2030
        3.3.1 Global Medical Liquid Embolic Agents Revenue by Region: 2019-2024
        3.3.2 Global Medical Liquid Embolic Agents Revenue by Region: 2025-2030
    3.4 North America Medical Liquid Embolic Agents Market Facts & Figures by Country
        3.4.1 North America Medical Liquid Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
        3.4.2 North America Medical Liquid Embolic Agents Sales by Country (2019-2030)
        3.4.3 North America Medical Liquid Embolic Agents Revenue by Country (2019-2030)
        3.4.4 United States
        3.4.5 Canada
    3.5 Europe Medical Liquid Embolic Agents Market Facts & Figures by Country
        3.5.1 Europe Medical Liquid Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
        3.5.2 Europe Medical Liquid Embolic Agents Sales by Country (2019-2030)
        3.5.3 Europe Medical Liquid Embolic Agents Revenue by Country (2019-2030)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Medical Liquid Embolic Agents Market Facts & Figures by Region
        3.6.1 Asia Pacific Medical Liquid Embolic Agents Market Size by Region: 2019 VS 2023 VS 2030
        3.6.2 Asia Pacific Medical Liquid Embolic Agents Sales by Region (2019-2030)
        3.6.3 Asia Pacific Medical Liquid Embolic Agents Revenue by Region (2019-2030)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 China Taiwan
        3.6.10 Southeast Asia
    3.7 Latin America Medical Liquid Embolic Agents Market Facts & Figures by Country
        3.7.1 Latin America Medical Liquid Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
        3.7.2 Latin America Medical Liquid Embolic Agents Sales by Country (2019-2030)
        3.7.3 Latin America Medical Liquid Embolic Agents Revenue by Country
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
        3.7.7 Colombia
    3.8 Middle East and Africa Medical Liquid Embolic Agents Market Facts & Figures by Country
        3.8.1 Middle East and Africa Medical Liquid Embolic Agents Market Size by Country: 2019 VS 2023 VS 2030
        3.8.2 Middle East and Africa Medical Liquid Embolic Agents Sales by Country (2019-2030)
        3.8.3 Middle East and Africa Medical Liquid Embolic Agents Revenue by Country
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 UAE

 4 Segment by Type
    4.1 Global Medical Liquid Embolic Agents Sales by Type (2019-2030)
        4.1.1 Global Medical Liquid Embolic Agents Sales by Type (2019-2024)
        4.1.2 Global Medical Liquid Embolic Agents Sales by Type (2025-2030)
        4.1.3 Global Medical Liquid Embolic Agents Sales Market Share by Type (2019-2030)
    4.2 Global Medical Liquid Embolic Agents Revenue by Type (2019-2030)
        4.2.1 Global Medical Liquid Embolic Agents Revenue by Type (2019-2024)
        4.2.2 Global Medical Liquid Embolic Agents Revenue by Type (2025-2030)
        4.2.3 Global Medical Liquid Embolic Agents Revenue Market Share by Type (2019-2030)
    4.3 Global Medical Liquid Embolic Agents Price by Type (2019-2030)

 5 Segment by Application
    5.1 Global Medical Liquid Embolic Agents Sales by Application (2019-2030)
        5.1.1 Global Medical Liquid Embolic Agents Sales by Application (2019-2024)
        5.1.2 Global Medical Liquid Embolic Agents Sales by Application (2025-2030)
        5.1.3 Global Medical Liquid Embolic Agents Sales Market Share by Application (2019-2030)
    5.2 Global Medical Liquid Embolic Agents Revenue by Application (2019-2030)
        5.2.1 Global Medical Liquid Embolic Agents Revenue by Application (2019-2024)
        5.2.2 Global Medical Liquid Embolic Agents Revenue by Application (2025-2030)
        5.2.3 Global Medical Liquid Embolic Agents Revenue Market Share by Application (2019-2030)
    5.3 Global Medical Liquid Embolic Agents Price by Application (2019-2030)

 6 Key Companies Profiled
    6.1 Medtronic
        6.1.1 Medtronic Company Information
        6.1.2 Medtronic Description and Business Overview
        6.1.3 Medtronic Medical Liquid Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
        6.1.4 Medtronic Medical Liquid Embolic Agents Product Portfolio
        6.1.5 Medtronic Recent Developments/Updates
    6.2 Balt Group
        6.2.1 Balt Group Company Information
        6.2.2 Balt Group Description and Business Overview
        6.2.3 Balt Group Medical Liquid Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
        6.2.4 Balt Group Medical Liquid Embolic Agents Product Portfolio
        6.2.5 Balt Group Recent Developments/Updates
    6.3 Johnson & Johnson
        6.3.1 Johnson & Johnson Company Information
        6.3.2 Johnson & Johnson Description and Business Overview
        6.3.3 Johnson & Johnson Medical Liquid Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
        6.3.4 Johnson & Johnson Medical Liquid Embolic Agents Product Portfolio
        6.3.5 Johnson & Johnson Recent Developments/Updates
    6.4 Meril Life
        6.4.1 Meril Life Company Information
        6.4.2 Meril Life Description and Business Overview
        6.4.3 Meril Life Medical Liquid Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
        6.4.4 Meril Life Medical Liquid Embolic Agents Product Portfolio
        6.4.5 Meril Life Recent Developments/Updates
    6.5 BlackSwan Vascular
        6.5.1 BlackSwan Vascular Company Information
        6.5.2 BlackSwan Vascular Description and Business Overview
        6.5.3 BlackSwan Vascular Medical Liquid Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
        6.5.4 BlackSwan Vascular Medical Liquid Embolic Agents Product Portfolio
        6.5.5 BlackSwan Vascular Recent Developments/Updates
    6.6 Success Bio-Tech
        6.6.1 Success Bio-Tech Company Information
        6.6.2 Success Bio-Tech Description and Business Overview
        6.6.3 Success Bio-Tech Medical Liquid Embolic Agents Sales, Revenue and Gross Margin (2019-2024)
        6.6.4 Success Bio-Tech Medical Liquid Embolic Agents Product Portfolio
        6.6.5 Success Bio-Tech Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Medical Liquid Embolic Agents Industry Chain Analysis
    7.2 Medical Liquid Embolic Agents Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Medical Liquid Embolic Agents Production Mode & Process
    7.4 Medical Liquid Embolic Agents Sales and Marketing
        7.4.1 Medical Liquid Embolic Agents Sales Channels
        7.4.2 Medical Liquid Embolic Agents Distributors
    7.5 Medical Liquid Embolic Agents Customers

 8 Medical Liquid Embolic Agents Market Dynamics
    8.1 Medical Liquid Embolic Agents Industry Trends
    8.2 Medical Liquid Embolic Agents Market Drivers
    8.3 Medical Liquid Embolic Agents Market Challenges
    8.4 Medical Liquid Embolic Agents Market Restraints

 9 Research Findings and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Medical Liquid Embolic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Medical Liquid Embolic Agents Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Medical Liquid Embolic Agents Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Medical Liquid Embolic Agents Sales (K Dose) of Key Manufacturers (2019-2024)
 Table 5. Global Medical Liquid Embolic Agents Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Medical Liquid Embolic Agents Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Medical Liquid Embolic Agents Average Price (US$/Dose) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Medical Liquid Embolic Agents, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Medical Liquid Embolic Agents, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Medical Liquid Embolic Agents, Product Type & Application
 Table 12. Global Key Manufacturers of Medical Liquid Embolic Agents, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Medical Liquid Embolic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Liquid Embolic Agents as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Medical Liquid Embolic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Medical Liquid Embolic Agents Sales by Region (2019-2024) & (K Dose)
 Table 18. Global Medical Liquid Embolic Agents Sales Market Share by Region (2019-2024)
 Table 19. Global Medical Liquid Embolic Agents Sales by Region (2025-2030) & (K Dose)
 Table 20. Global Medical Liquid Embolic Agents Sales Market Share by Region (2025-2030)
 Table 21. Global Medical Liquid Embolic Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Medical Liquid Embolic Agents Revenue Market Share by Region (2019-2024)
 Table 23. Global Medical Liquid Embolic Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Medical Liquid Embolic Agents Revenue Market Share by Region (2025-2030)
 Table 25. North America Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Medical Liquid Embolic Agents Sales by Country (2019-2024) & (K Dose)
 Table 27. North America Medical Liquid Embolic Agents Sales by Country (2025-2030) & (K Dose)
 Table 28. North America Medical Liquid Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Medical Liquid Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Medical Liquid Embolic Agents Sales by Country (2019-2024) & (K Dose)
 Table 32. Europe Medical Liquid Embolic Agents Sales by Country (2025-2030) & (K Dose)
 Table 33. Europe Medical Liquid Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Medical Liquid Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Medical Liquid Embolic Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Medical Liquid Embolic Agents Sales by Region (2019-2024) & (K Dose)
 Table 37. Asia Pacific Medical Liquid Embolic Agents Sales by Region (2025-2030) & (K Dose)
 Table 38. Asia Pacific Medical Liquid Embolic Agents Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Medical Liquid Embolic Agents Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Medical Liquid Embolic Agents Sales by Country (2019-2024) & (K Dose)
 Table 42. Latin America Medical Liquid Embolic Agents Sales by Country (2025-2030) & (K Dose)
 Table 43. Latin America Medical Liquid Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Medical Liquid Embolic Agents Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Medical Liquid Embolic Agents Sales by Country (2019-2024) & (K Dose)
 Table 47. Middle East and Africa Medical Liquid Embolic Agents Sales by Country (2025-2030) & (K Dose)
 Table 48. Middle East and Africa Medical Liquid Embolic Agents Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Medical Liquid Embolic Agents Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Medical Liquid Embolic Agents Sales (K Dose) by Type (2019-2024)
 Table 51. Global Medical Liquid Embolic Agents Sales (K Dose) by Type (2025-2030)
 Table 52. Global Medical Liquid Embolic Agents Sales Market Share by Type (2019-2024)
 Table 53. Global Medical Liquid Embolic Agents Sales Market Share by Type (2025-2030)
 Table 54. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Medical Liquid Embolic Agents Revenue Market Share by Type (2019-2024)
 Table 57. Global Medical Liquid Embolic Agents Revenue Market Share by Type (2025-2030)
 Table 58. Global Medical Liquid Embolic Agents Price (US$/Dose) by Type (2019-2024)
 Table 59. Global Medical Liquid Embolic Agents Price (US$/Dose) by Type (2025-2030)
 Table 60. Global Medical Liquid Embolic Agents Sales (K Dose) by Application (2019-2024)
 Table 61. Global Medical Liquid Embolic Agents Sales (K Dose) by Application (2025-2030)
 Table 62. Global Medical Liquid Embolic Agents Sales Market Share by Application (2019-2024)
 Table 63. Global Medical Liquid Embolic Agents Sales Market Share by Application (2025-2030)
 Table 64. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Medical Liquid Embolic Agents Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Medical Liquid Embolic Agents Revenue Market Share by Application (2019-2024)
 Table 67. Global Medical Liquid Embolic Agents Revenue Market Share by Application (2025-2030)
 Table 68. Global Medical Liquid Embolic Agents Price (US$/Dose) by Application (2019-2024)
 Table 69. Global Medical Liquid Embolic Agents Price (US$/Dose) by Application (2025-2030)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 73. Medtronic Medical Liquid Embolic Agents Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Balt Group Company Information
 Table 76. Balt Group Description and Business Overview
 Table 77. Balt Group Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 78. Balt Group Medical Liquid Embolic Agents Product
 Table 79. Balt Group Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 83. Johnson & Johnson Medical Liquid Embolic Agents Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Meril Life Company Information
 Table 86. Meril Life Description and Business Overview
 Table 87. Meril Life Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 88. Meril Life Medical Liquid Embolic Agents Product
 Table 89. Meril Life Recent Developments/Updates
 Table 90. BlackSwan Vascular Company Information
 Table 91. BlackSwan Vascular Description and Business Overview
 Table 92. BlackSwan Vascular Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 93. BlackSwan Vascular Medical Liquid Embolic Agents Product
 Table 94. BlackSwan Vascular Recent Developments/Updates
 Table 95. Success Bio-Tech Company Information
 Table 96. Success Bio-Tech Description and Business Overview
 Table 97. Success Bio-Tech Medical Liquid Embolic Agents Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
 Table 98. Success Bio-Tech Medical Liquid Embolic Agents Product
 Table 99. Success Bio-Tech Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Medical Liquid Embolic Agents Distributors List
 Table 103. Medical Liquid Embolic Agents Customers List
 Table 104. Medical Liquid Embolic Agents Market Trends
 Table 105. Medical Liquid Embolic Agents Market Drivers
 Table 106. Medical Liquid Embolic Agents Market Challenges
 Table 107. Medical Liquid Embolic Agents Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Medical Liquid Embolic Agents
 Figure 2. Global Medical Liquid Embolic Agents Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Medical Liquid Embolic Agents Market Share by Type: 2023 & 2030
 Figure 4. EVOH-Based Product Picture
 Figure 5. Diluted Cyanoacrylate Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Medical Liquid Embolic Agents Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Medical Liquid Embolic Agents Market Share by Application: 2023 & 2030
 Figure 9. Brain Arterio-Venous Malformations (bAVM)
 Figure 10. Tumor Embolization
 Figure 11. Others
 Figure 12. Global Medical Liquid Embolic Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Medical Liquid Embolic Agents Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Medical Liquid Embolic Agents Sales (2019-2030) & (K Dose)
 Figure 15. Global Medical Liquid Embolic Agents Average Price (US$/Dose) & (2019-2030)
 Figure 16. Medical Liquid Embolic Agents Report Years Considered
 Figure 17. Medical Liquid Embolic Agents Sales Share by Manufacturers in 2023
 Figure 18. Global Medical Liquid Embolic Agents Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Medical Liquid Embolic Agents Players: Market Share by Revenue in Medical Liquid Embolic Agents in 2023
 Figure 20. Medical Liquid Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Medical Liquid Embolic Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Medical Liquid Embolic Agents Sales Market Share by Country (2019-2030)
 Figure 23. North America Medical Liquid Embolic Agents Revenue Market Share by Country (2019-2030)
 Figure 24. United States Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Medical Liquid Embolic Agents Sales Market Share by Country (2019-2030)
 Figure 27. Europe Medical Liquid Embolic Agents Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Medical Liquid Embolic Agents Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Medical Liquid Embolic Agents Revenue Market Share by Region (2019-2030)
 Figure 35. China Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Medical Liquid Embolic Agents Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Medical Liquid Embolic Agents Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Medical Liquid Embolic Agents Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Medical Liquid Embolic Agents Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Medical Liquid Embolic Agents by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Medical Liquid Embolic Agents by Type (2019-2030)
 Figure 54. Global Medical Liquid Embolic Agents Price (US$/Dose) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Medical Liquid Embolic Agents by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Medical Liquid Embolic Agents by Application (2019-2030)
 Figure 57. Global Medical Liquid Embolic Agents Price (US$/Dose) by Application (2019-2030)
 Figure 58. Medical Liquid Embolic Agents Value Chain
 Figure 59. Medical Liquid Embolic Agents Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed

Description

The global market for Medical Liquid Embolic Agents was valued at US$ 133 million in the year 2023 and is projected to reach a revised size of US$ 222 million by 2030, growing at a CAGR of 7.6% during the forecast period.

Medical liquid embolic agents are specialized substances used in interventional radiology to block blood flow in targeted blood vessels, typically for treating vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, or tumors. These agents are delivered via a catheter and solidify or precipitate upon contact with blood or tissue, creating a durable embolization effect. Common types include cyanoacrylate glues, ethylene-vinyl alcohol copolymer (EVOH), and onyx-based systems, which vary in composition, viscosity, and application methods. They offer a minimally invasive treatment option, reducing the need for open surgery while providing precise vascular occlusion to manage bleeding or cut off blood supply to abnormal tissues.

North American market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Market Segmentation

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region,  by Type,  by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Liquid Embolic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Liquid Embolic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Industry: Pharma & Healthcare

Published: 2024-12-21

Pages: 80 Pages

Report ld: 3407389

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 2900.00

Multi Users License

USD 4350.00

Corporate Users License